Cryo-Cell International (Cryo-Cell) has reported the progress in the fight against breast cancer through research and development using stem cells from menstrual blood.
The company said that it is supporting Susan Komen for the Cure through C’elle, the company’s service which enables women to collect and cryopreserve stem cells from their menstrual blood.
Reportedly, Cryo-Cell is in a research partnership with the National Institutes of Health (NIH) Clinical Center, where research is underway to better understand the C’elle stem cells and their potential benefit for the treatment of breast cancer.
Since launching its proprietary service nearly two years ago, the company continues to expand research and development initiatives in order to accelerate the diagnostic and therapeutic benefits of these stem cells.
Mercedes Walton, CEO at Cryo-Cell, said: “Through our partnership with the NIH, it is exciting to have such an integral role in research to understand how C’elle stem cells might help to treat breast cancer. I continue to be inspired by all of the strong and courageous women out there who fight this disease, so it’s an honor to support Susan G. Komen for the Cure.”